Print（PDF/163KB） Jan. 15, 2024 Sustainability

Sumitomo Pharma Contributes to the 2024 Noto Peninsula Earthquake Relief Efforts in Japan

Sumitomo Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President and CEO: Hiroshi Nomura) expresses its deepest condolences to those who lost their lives in the 2024 Noto Peninsula Earthquake and its deepest sympathy for victims of the earthquake.

Sumitomo Pharma announced today that the Company will make a donation of JPY 10 million through the Central Community Chest of Japan to aid relief efforts for victims of the earthquake.

Sumitomo Pharma sincerely prays for the rapid recovery of the afflicted regions.